Among CKD causes, type 2 diabetes mellitus is notably the only condition demonstrating a significant increase in age-standardized DALY rates between 1990 and 2017, accounting for one-third of CKD-attributable DALYs [2]
Relationship between diet/exercise and pharmacotherapy to enhance the GLP-1 levels in type 2 diabetes
Dulaglutide (Trulicity) Once-weekly injection, better tolerated but modest results (35% weight loss)
With telehealth providers like Hers, Nurx, Ro, and Alloy, you can book a virtual consultation with a medical provider to learn more about your candidacy and whether or not these weight loss medications are the right option for you
Amylin, another important neuroendocrine hormone for the treatment of diabesity
Common eligibility criteria may include: BMI of 30 or higher BMI of 27 or higher with at least one weight-related health condition History of failed diet attempts or weight regain Appetite, cravings, or portion control challenges Metabolic risk factors such as insulin resistance, elevated glucose, high cholesterol, or hypertension Need for physician-supervised weight loss due to medical complexity Eligibility must be determined through a medical consultation
